Heidi Taipale: a curiosity-driven approach to data

“Clinical trials often operate under ideal conditions with highly motivated participants, but real-world patients are more diverse and face different challenges. Our registry-based studies reflect this reality.” Since 2017, Heidi Taipale and her colleagues have been using the Nordic registries—a large data source on individual-level and population-level health from Denmark, Finland, Iceland, Norway, and Sweden—to conduct groundbreaking psychiatric pharmacoepidemiology studies. With resounding results in relation to clozapine and schizophrenia treatment, Taipale has become a leading figure within the field.